(Q48469848)

11 February 2018

title

Reply to 'Promotion of sleep by targeting the orexin system in rats, dogs and humans'. (English)

1 reference

11 February 2018

author

Mehdi Tafti

series ordinal

1

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 May 2007

1 reference

11 February 2018

published in

Nature Medicine

1 reference

11 February 2018

volume

13

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

page(s)

525-6; author reply 526

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1038/nm0507-525

exact match

0 references

cites work

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1038%2FNM0507-525

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1038%2FNM0507-525

7 January 2021

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias

1 reference

https://api.crossref.org/works/10.1038%2FNM0507-525

7 January 2021

Narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1038%2FNM0507-525

7 January 2021

Promotion of sleep by targeting the orexin system in rats, dogs and humans

1 reference

https://api.crossref.org/works/10.1038%2FNM0507-525

7 January 2021

Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy.

1 reference

https://api.crossref.org/works/10.1038%2FNM0507-525

7 January 2021

Identifiers

DOI

10.1038/NM0507-525

1 reference

11 February 2018

PubMed ID

17479088

1 reference

11 February 2018